Rifampicin News and Research

RSS
New test detects TB faster, with more accuracy than current diagnostics, study says

New test detects TB faster, with more accuracy than current diagnostics, study says

Philippine FDA's LSD attains ISO/IEC 17025:2005 accreditation for testing and calibration laboratories

Philippine FDA's LSD attains ISO/IEC 17025:2005 accreditation for testing and calibration laboratories

Bayer signs agreement to supply Adalat XL product to Teva Canada

Bayer signs agreement to supply Adalat XL product to Teva Canada

Antwerp ITM calls for change in WHO guidelines on Buruli ulcer

Antwerp ITM calls for change in WHO guidelines on Buruli ulcer

Scientists awarded $3.9M grant to study how XDR-TB transmitted in rural South Africa

Scientists awarded $3.9M grant to study how XDR-TB transmitted in rural South Africa

Bayer's Adalat XL product and Mylan's nifedipine extended release 60 mg not bioequivalent: Study

Bayer's Adalat XL product and Mylan's nifedipine extended release 60 mg not bioequivalent: Study

Cepheid to launch GeneXpert Infinity-48 in Europe at 20th ECCMID

Cepheid to launch GeneXpert Infinity-48 in Europe at 20th ECCMID

New WHO report estimates 440,000 MDR-TB cases worldwide in 2008

New WHO report estimates 440,000 MDR-TB cases worldwide in 2008

WHO estimates 440 000 MDR-TB cases in 2008

WHO estimates 440 000 MDR-TB cases in 2008

Study: Generic nifedipine product not bioequivalent to Adalat XL

Study: Generic nifedipine product not bioequivalent to Adalat XL

Swedish study opens new potential for combating resistant bacteria

Swedish study opens new potential for combating resistant bacteria

Rifampicin resistant tuberculosis

Rifampicin resistant tuberculosis

Results of IES presented at ECCO

Results of IES presented at ECCO

MSD's ISENTRESS approved by the EU Commission for treating HIV-1 infection in adult patients

MSD's ISENTRESS approved by the EU Commission for treating HIV-1 infection in adult patients

Increase in Rifampicin dosage shortens tuberculosis treatment duration

Increase in Rifampicin dosage shortens tuberculosis treatment duration

Lancet Infectious Diseases examines spread of XDR-TB

Lancet Infectious Diseases examines spread of XDR-TB

Slow-growing tuberculosis bacteria point the way to new drug development

Slow-growing tuberculosis bacteria point the way to new drug development

How RNA polymerase kick starts gene activation revealed

How RNA polymerase kick starts gene activation revealed

TB Alliance enters into collaboration with sanofi-aventis to fight tuberculosis

TB Alliance enters into collaboration with sanofi-aventis to fight tuberculosis

Certain HIV treatment less effective when used with rifampicin-based anti-tuberculosis therapy

Certain HIV treatment less effective when used with rifampicin-based anti-tuberculosis therapy